MIMEDX GROUP INC - COMMON STOCK

MIMEDX Announces Strategic Realignment: Increases Focus on Wound & Surgical Business, Expected to Significantly Improve Profitability

20 Jun 2023 15:01:00 By Nasdaq GlobeNewswire

MIMEDX Announces First Quarter 2023 Operating and Financial Results

02 May 2023 15:01:00 By Nasdaq GlobeNewswire

MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2

18 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

MIMEDX Announces Chief Financial Officer Transition

23 Mar 2023 15:01:00 By Nasdaq GlobeNewswire

MIMEDX Comments on Recent Data Brief Published by Office of Inspector General

16 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial Results

28 Feb 2023 15:01:01 By Nasdaq GlobeNewswire

MIMEDX to Host Fourth Quarter and Full Year 2022 Operating and Financial Results Conference Call on February 28

15 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director

30 Jan 2023 07:00:01 By Nasdaq GlobeNewswire

MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate Updates

09 Jan 2023 07:03:58 By Nasdaq GlobeNewswire

MIMEDX Announces Commercial Launch of EPIFIX® in Japan with Exclusive Distribution Agreement with GUNZE MEDICAL LIMITED

04 Jan 2023 15:01:00 By Nasdaq GlobeNewswire

MIMEDX Appoints Ricci S. Whitlow as Chief Operating Officer

03 Jan 2023 07:00:01 By Nasdaq GlobeNewswire

MIMEDX Announces Wound & Surgical Product Pipeline Expansion via In-Licensing and Distribution Agreement with Turn Therapeutics

08 Dec 2022 07:00:01 By Nasdaq GlobeNewswire

MIMEDX to Present at Upcoming Investor Conferences

10 Nov 2022 07:00:02 By Nasdaq GlobeNewswire

MIMEDX Announces Third Quarter 2022 Operating and Financial Results

02 Nov 2022 15:15:01 By Nasdaq GlobeNewswire

MIMEDX to Host Third Quarter 2022 Operating and Financial Results Conference Call on November 2

19 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

MIMEDX Appoints Matt Notarianni as Head of Investor Relations

04 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

MIMEDX Announces Launch of AXIOFILL™

20 Sep 2022 07:00:02 By Nasdaq GlobeNewswire

MIMEDX Announces Launch of AMNIOEFFECT™

19 Sep 2022 06:00:00 By Nasdaq GlobeNewswire

MIMEDX EPIFIX® Receives Reimbursement Approval in Japan

12 Sep 2022 15:30:00 By Nasdaq GlobeNewswire

MIMEDX Announces Leadership Transition

06 Sep 2022 06:00:00 By Nasdaq GlobeNewswire